Loading company…
Suzhou Huayi Lejian Biotechnology develops gene therapies and biopharmaceutical products.
Established in 2019 and based in Suzhou, China, Suzhou Huayi Lejian Biotechnology develops biopharmaceutical products, including gene therapies for hemophilia A and other target areas. Its AAV gene therapy platform has products in clinical trials, and the company operates a cGMP production base. It also established an R&D center in Beijing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Suzhou Huayi Lejian Biotechnology Co., Ltd.? This is my company